Training therapists to coach individuals with a neurological condition to use the SMART Arm.
- Conditions
- StrokeNeurological conditionsStroke - IschaemicStroke - HaemorrhagicNeurological - Other neurological disorders
- Registration Number
- ACTRN12616000447459
- Lead Sponsor
- James Cook University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Withdrawn
- Sex
- All
- Target Recruitment
- 50
1) Individuals with a neurological condition
Inclusion: Individuals with a neurological condition aged over 15 years whose arm function has been reduced as a result of the neurological condition, and that receive a service from Community Rehab nQ during the study period.
2) Occupational therapists, physiotherapists and rehabilitation assistants working at CRnQ who have participated in basic SMART Arm training as a minimum.
Individuals with a neurological condition who are unable to 'actively participate' in SMART Arm training. For example people with cognitive-linguistic impairments that limit their ability to understand and follow instructions sufficiently to enable participation.
Occupational Therapists, Physiotherapists and Rehab Assistants who have not received the basic SMART Arm training will be excluded from the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Strengths and weaknesses of current SMART Arm coaching will be assessed concurrently. This outcome will be assessed via a survey questionnaire designed specifically for this study. <br>All participating individuals will complete the survey questionnaire. A selection of participating individuals with a neurological condition and a selection of clinicians will be invited to participate in individual or focus group interviews to verify and explain the survey findings. [3 months after commencement of the trial]
- Secondary Outcome Measures
Name Time Method Therapists capability to coach individuals with a neurological condition to use the SMART Arm. This will be assessed using a capability assessment tool designed specifically for this study by participating individuals with a neurological condition and via self-report by participating clinicians. [6 months after commencement of the trial. ]